from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1484/inhA

LFCtreatmentdescriptionclass of inhibitor

-1.062

Amikacinug/mL Amikacintranslation

-1.819

Cap5-10ug/mL Capreomycintranslation

-2.320

Rox10-50 ug/mL Roxithromycintranslation

0.165

SM2-5 ug/mL Streptomycintranslation

-2.998

Tet5-10 ug/mL Tetracyclinetranslation

0.507

Rif0.2-5ug/mL Rifampicintranscription

-1.186

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.300

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.740

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.701

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.014

Clofazimine10-13 ug/mL Clofaziminerespiration

0.031

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.922

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.560

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.712

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.439

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.354

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.291

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.477

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.395

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.365

KCN5-20 ug/mL Potassium cyaniderespiration

1.451

NaN30.2-2 mM Sodium aziderespiration

0.120

Nigericin50 uM Nigericinrespiration

-0.867

TRC10-150 ug/mL Triclosanrespiration

-1.214

TRZ10-25 ug/mL Thioridazinerespiration

-1.735

Valinomycin0.5-10 uM Valinomycinrespiration

0.909

ZnSO42 mM ZnSO4respiration

0.622

menadione6-10 ug/mL Menadionerespiration

0.230

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.281

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.215

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.151

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.857

NRP_1Non-replicating persistence stage 1dosRassociated

0.266

Amp0.2mg/mL AmpicillincellWall

0.481

Cephalexin20-100 ug/mL CephalexincellWall

-0.068

Cerulenin0.32-5 ug/mL CerulenincellWall

0.247

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.585

EMB10-20 ug/mL EthambutolcellWall

0.464

Eta12-40 ug/mL EthionamidecellWall

0.891

INH0.2-0.4 ug/mL IsoniazidcellWall

0.592

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.119

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.136

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.638

BZA0.12 mg/mL BenzamidearomaticAmides

0.385

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.101

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.276

H2O24 mM hydrogen peroxideDNAdamaging

-0.888

Levo10 ug/mL LevofloxacinDNAdamaging

0.293

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.212

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.543

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.441

UVUV-irradiationDNAdamaging

-0.158

ARP41-4 ug/mL Antitubercular compound ARP4?

0.590

Antimycin12.5-50 ug/mL Antimycin A?

0.284

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.898

PA_110-50 ug/mL Antitubercular compound PA-1?

0.976

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.757

PA8240.2-2 ug/mL PA-824?

0.574

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.783

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.274

Verapamil50 uM Verapamil?

0.039

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.323

methoxatin10-20 ug/mL Methoxatin?